REZLIDHIA vs RYDAPT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. REZLIDHIA and RYDAPT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	REZLIDHIA	RYDAPT
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	OLUTASIDENIB	MIDOSTAURIN
Manufacturer	Rigel Pharms	Novartis
Dosage forms	Capsule	Capsule
Drug class	—	—
Boxed warning	Boxed warning	None
Treats	Acute Myeloid Leukemia	Acute Myeloid Leukemia, Hematologic Neoplasms, Systemic Mastocytosis

rezlidhia rydapt

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

OLUTASIDENIB

MIDOSTAURIN

Manufacturer

Rigel Pharms

Novartis

Dosage forms

Capsule

Drug class

—

Boxed warning

None

Treats

Acute Myeloid Leukemia

Acute Myeloid Leukemia, Hematologic Neoplasms, Systemic Mastocytosis

Frequently asked questions

What is the difference between Rezlidhia and Rydapt?

Rezlidhia contains Olutasidenib, while Rydapt contains Midostaurin — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.